Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
Frontiers in Cardiovascular Medicine, 2022 Most patients present for catheter ablation of atrial fibrillation (CAAF) with residual or full effect of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs).
Michael Hardy +8 more
doaj +2 more sources
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data [PDF]
Thrombosis Journal, 2022 Background For stroke prevention in patients with atrial fibrillation (AF), direct oral anticoagulants (DOACs) have been increasingly prescribed instead of vitamin-K-antagonists (VKA).
Lisette Warkentin +4 more
doaj +2 more sources
Influence of DOACS and DOAC-REMOVE® on coagulation assays during thrombophilia testing in DOAC-treated patients [PDF]
Vojnosanitetski pregled, 2022 Background/Aim. Direct oral anticoagulants (DOACs) administration significantly interferes with coagulation as-says. The aim of the study was to evaluate the effect of DOACs and DOAC-Remove? on coagulation assays during thrombophilia testing. Methods. The study was carried out from January 2019 to the end of June 2020.
Mirjana Kovac +5 more
openaire +4 more sources
Practical issues in measuring the anticoagulant effect of direct oral anticoagulants [PDF]
Arhiv za farmaciju, 2020 The classical oral anticoagulants are increasingly being replaced in clinical practice by new antithrombotic drugs, which act by enabling direct inhibition of coagulation factor IIa (FIIa) or factor Xa (FXa). These drugs have multiple acronyms, including
Dopsaj Violeta
doaj +1 more source
Journal of Scientific Innovation in Medicine, 2021 Over the years, the number of patients with end-stage renal disease (ESRD) have been steadily increasing. Cardiovascular causes account for 55.2% of all deaths among ESRD patients.
Mahmoud Khalifa +2 more
doaj +1 more source
Evaluation of Potentially Inappropriate Medication of Direct Oral Anticoagulant in Hospitalized Elderly Patients with Non-valvular Atrial Fibrillation Based on Beers Criteria [PDF]
Zhongguo quanke yixue, 2023 Background Direct oral anticoagulants (DOACs) have gradually replaced the vitamin K antagonist warfarin and become the first line drugs for anticoagulant therapy in patients with non-valvular atrial fibrillation (NVAF), however, the safety and efficacy ...
LIU Puqing, CHEN Jingwen, SHOU Zhangxuan
doaj +1 more source
Frontiers in Bioscience-Scholar, 2022 The most frequent arrhythmia treated is atrial fibrillation (AF), which necessitates the use of oral anticoagulants (OACs) to reduce the risk of thromboembolism and stroke.
Nikolaos Ktenopoulos +4 more
doaj +1 more source
Availability, use and development of animal models for the assessment of drug-drug interactions and safety of direct oral anticoagulants [PDF]
Kafkas Universitesi Veteriner Fakültesi Dergisi, 2018 Direct oral anticoagulants (DOACs) are novel, direct acting drugs that are selective for either thrombin or activated factor X. Due to their obvious benefits for patients (broader therapeutic window, are not routinely monitored etc.), they are ...
Ipek KOMSUOGLU CELIKYURT
doaj +1 more source
Reviews in Cardiovascular Medicine, 2023 Acute coronary syndrome (ACS) is a leading cause of mortality worldwide. Despite optimal antiplatelet therapy recommendation after ischemic events, recurrent thrombotic complications rate remains high.
Rasha Kaddoura +3 more
doaj +1 more source
DOACs for stroke prevention in patients with AF and cancer [PDF]
, 2020 Stroke prophylaxis in atrial fibrillation is an important consideration in patients with cancer. However, there is little consensus on the choice of anticoagulation, due to the numerous difficulties associated with active cancer.
Guha, Avirup +8 more
core +2 more sources